Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
Patrick BidulkaEdouard L FuClémence LeyratFotini KalogirouKatherine S L McAllisterEdward J KingdonKathryn E MansfieldMasao IwagamiLiam SmeethCatherine M ClaseKrishnan BhaskaranMerel van DiepenJuan-Jesus CarreroDorothea NitschLaurie A TomlinsonPublished in: BMC medicine (2020)
Previous ACEI/ARB users who continued treatment after an episode of AKI did not have an increased risk of heart failure or subsequent AKI compared to those who stopped the drugs.